These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7658326

  • 21. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC, Huang TP, Chen TW, Yang WC.
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [Abstract] [Full Text] [Related]

  • 22. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M, Uday K, Henriquez M, Blum S, Dave M.
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract] [Full Text] [Related]

  • 23. Iron metabolism and iron substitution during erythropoietin therapy.
    Sunder-Plassmann G, Hörl WH.
    Clin Investig; 1994 Jul; 72(6 Suppl):S11-5. PubMed ID: 7950165
    [Abstract] [Full Text] [Related]

  • 24. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M.
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB.
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [Abstract] [Full Text] [Related]

  • 31. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
    Barosi G, Merlo C, Palestra P, Liberato NL, Guarnone R, Di Dio F, Piazza V, Salvadeo A.
    Acta Haematol; 1993 Aug; 90(1):13-8. PubMed ID: 8237268
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
    Sowade O, Messinger D, Franke W, Sowade B, Scigalla P, Warnke H.
    Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
    Wingard RL, Parker RA, Ismail N, Hakim RM.
    Am J Kidney Dis; 1995 Mar; 25(3):433-9. PubMed ID: 7872321
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences.
    Grützmacher P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kaltwasser J, Kurz P, Scheuermann EH, Schoeppe W.
    Clin Nephrol; 1992 Mar; 38 Suppl 1():S92-7. PubMed ID: 1295714
    [Abstract] [Full Text] [Related]

  • 40. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC, Tsai TJ, Chen YM, Lin SL, Hsieh BS.
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.